Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,785
Closed -$221K 909
2025
Q1
$250K Buy
2,785
+80
+3% +$7.47K 0.01% 737
2024
Q4
$269K Sell
2,705
-6,276
-70% -$647K 0.01% 715
2024
Q3
$1.02M Sell
8,981
-5,109
-36% -$607K 0.02% 492
2024
Q2
$1.74M Sell
14,090
-11,381
-45% -$1.47M 0.04% 395
2024
Q1
$3.36M Buy
+25,471
New +$3.14M 0.2% 56
2023
Q4
Sell
-32,302
Closed -$3.33M 1107
2023
Q3
$3.33M Buy
32,302
+14,812
+85% +$1.6M 0.04% 271
2023
Q2
$2.02M Buy
+17,490
New +$1.99M 0.03% 294
2022
Q4
Sell
-19,586
Closed -$2M 1022
2022
Q3
$1.69M Buy
19,586
+16,342
+504% +$1.46M 0.03% 367
2022
Q2
$296K Buy
3,244
+276
+9% +$24.5K 0.01% 753
2022
Q1
$244K Buy
+2,968
New +$234K 0.01% 752
2021
Q3
Sell
-8,019
Closed -$610K 1192
2021
Q2
$624K Buy
+8,019
New +$596K 0.03% 581
2020
Q3
Sell
-4,889
Closed -$383K 706
2020
Q2
$361K Buy
+4,889
New +$368K 0.02% 369

Other funds holding MRK

Maven Securities's MRK Position: Q2 2025 in Review

Maven Securities sold out of Merck (MRK) in Q2 2025, closing a stake of 2,785 shares — an estimated $221K sold.

Maven Securities first reported a position in MRK in Q2 2020 and held it in 12 quarters. The position peaked at $3.36M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Maven Securities reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 2,785 Merck shares in Q2 2025, an estimated $221K.
  • Maven Securities first reported a position in Merck in Q2 2020 and held it in 12 quarters.
  • Maven Securities's Merck position peaked at $3.36M in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.